Cabaletta Bio CABA
NASDAQ CABA
$1.52 -0.02 (-1.30%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cabaletta Bio (CABA) EPS (Diluted) (2019 - 2026)

Updated

Cabaletta Bio (CABA) reported EPS (Diluted) of -$0.34 for Q2 2026, compared with -$0.73 a year earlier.

Analysis

Cabaletta Bio (CABA) EPS (Diluted) (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Cabaletta Bio's EPS (Diluted) came in at -$1.21; for FY2025, it was -$2.71.

  • By year, EPS (Diluted) came in at -$2.32 in FY2024, -$1.58 in FY2023, -$1.62 in FY2022 and -$1.54 in FY2021.
  • The Q2 2026 figure ranks as the highest quarterly EPS (Diluted) since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 7.94
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 0.09
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 2.04
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -0.54
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 1.67
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 1.60
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 4.37
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -8.44
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -0.04
10 Cabaletta Bio 213.89 Mn -11.21 Mn - -0.34
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.34
Dec 31, 2025 -0.68
Sep 30, 2025 -0.73
Jun 30, 2025 -0.73
Mar 31, 2025 -0.72
Dec 31, 2024 -0.65
Sep 30, 2024 -0.62
Jun 30, 2024 -0.55
Mar 31, 2024 -0.49
Dec 31, 2023 -0.49
Sep 30, 2023 -0.36
Jun 30, 2023 -0.35
Mar 31, 2023 -0.42
Dec 31, 2022 -0.48
Sep 30, 2022 -0.35
Jun 30, 2022 -0.40
Mar 31, 2022 -0.39
Dec 31, 2021 -0.46
Sep 30, 2021 -0.38
Jun 30, 2021 -0.38
API Access

Cabaletta Bio EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=CABA&period=max&api_key=YOUR_API_KEY